EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine



The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine



Endocrinology 117(4): 1448-1455



Human prolactinoma cells were maintained in culture for a period of at least 8 days and were able to secrete PRL in large amounts. This secretion was inhibited by bromocriptine, an agonist of dopaminergic receptors, in a dose-dependent manner. The cells showed electrical activity (action potentials) which was blocked by inhibitors of calcium current (cobalt, manganese), whereas it was insensitive to blockers of sodium current (tetrodotoxin). At the resting potential of the cell, dopamine induced a hyperpolarizing response such that action potentials no longer occurred. This effect was due to increase of the membrane conductance and depended on the cell potential. The reversal potential of this response was at -100 mV, which suggests the involvement of potassium ions. Bromocriptine and RU 24213, which are strong dopaminergic receptor agonists, both induced responses identical to the dopamine-induced response. The D2 receptor antagonists (haloperidol, domperidone, and spiperone) blocked the dopamine-induced response in a reversible manner. The D1 antagonist of dopaminergic receptors flupentixol had no effect on the dopamine response. It is concluded that the dopamine modulation of electrical activity involving calcium current may be an early important step in the mechanism by which dopamine inhibits PRL release.

(PDF emailed within 0-6 h: $19.90)

Accession: 041644854

Download citation: RISBibTeXText

PMID: 4029087

DOI: 10.1210/endo-117-4-1448



Related references

Control of phospholipid turnover and prolactin release in a dopamine-sensitive, prolactin-secreting rat pituitary adenoma and in two dopamine-resistant, prolactin-secreting rat pituitary tumors. Journal of Neuroendocrinology 2(6): 833-838, 1990

Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine. Comptes Rendus de L'academie des Sciences. Serie Iii, Sciences de la Vie 306(3): 129-134, 1988

Dopaminergic regulation of prolactin synthesis in human prolactin secreting adenoma cells in primary culture. Society for Neuroscience Abstracts 12(1): 5, 1986

Electrical properties of cultured human adrenocorticotropin-secreting adenoma cells: effects of high K+, corticotropin-releasing factor, and angiotensin II. Endocrinology 121(1): 395-405, 1987

Electrical properties of cultured human acth secreting adenoma cells effects of high potassium corticotropin releasing factor and angiotensin ii. Endocrinology 121(1): 395-405, 1987

HERG K(+) currents in human prolactin-secreting adenoma cells. Pflugers Archiv 445(5): 589-600, 2003

Human prolactin secreting adenoma cells maintained on extracellular matrix. Endocrinology 108(1): 357-360, 1981

Failure of 2 Hydroxyestradiol to interact with dopamine inhibition of human prolactin secretion in vitro and with dopamine receptors of prolactin-secreting adenomas. Biochemical and Biophysical Research Communications 112(1): 42-46, 1983

Calcium-dependent changes in electrical properties of prolactin-secreting anterior pituitary (2B8) clonal cells. Neuroendocrinology 32(1): 28-32, 1981

Reduced 3H-dopamine uptake by blood platelets in patients with prolactin-secreting pituitary adenoma. Hormone and Metabolic Research 14(6): 310-312, 1982

Solubilization and characterization of D2-dopamine receptors in an estrone-induced, prolactin-secreting rat pituitary adenoma. Journal of Neurochemistry 47(5): 1653-1660, 1986

Calmodulin content in human prolactin-secreting pituitary adenoma: an inverse relationship to serum prolactin levels. Neuroscience Letters 90(1-2): 224-228, 1988

Electrical responses induced by dopamine and trh on normal prolactin cells in primary culture their modification by 17 beta estradiol. Neuroscience 22(SUPPL): S150, 1987

Dopamine receptors in human prolactin secreting and growth hormone secreting adenomas. Camanni, F And E E Muller (Ed ) Serono Symposia Publications From Raven Press, Vol 10 Pituitary Hyperfunction: Physiopathology And Clinical Aspects Xviii+430p Raven Press: New York, N Y , Usa Illus P111-124, 1984

In vitro secretion of trh from human prolactin prl secreting adenomatous cells modulation by dopamine da. Metcalf, G And I M D Jackson (Ed ) Annals Of The New York Academy Of Sciences, Vol 553 Thyrotropin-Releasing Hormone: Biomedical Significance; Conference on Recent Advances in The Biomedical Significance Of Thyrotropin-Releasing Hormone (Trh), Bethesda, Maryland, Usa, November 9-11, 1987 Xvii+631p New York Academy Of Sciences: New York, New York, Usa Illus 540-542, 1989